The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease

83Citations
Citations of this article
136Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The quest for the ideal therapeutic target in chronic kidney disease (CKD) has been riddled with many obstacles stemming from the molecular complexity of the disease and its co-morbidities. Recent advances in omics technologies and the resulting amount of available data encompassing genomics, proteomics, peptidomics, transcriptomics and metabolomics has created an opportunity for integrating omics datasets to build a comprehensive and dynamic model of the molecular changes in CKD for the purpose of biomarker and drug discovery. This article reviews relevant concepts in omics data integration using systems biology, a mathematical modelling method that globally describes a biological system on the basis of itsmodules and the functional connections that govern their behaviour. The review describes key databases and bioinformatics tools, aswell as the challenges and limitations of the current state of the art, along with practical application to CKD therapeutic target discovery. Moreover, it describes howsystems biology and visualization tools can be used to generate clinically relevant molecularmodels with the capability to identify specific disease pathways, recognize key events in disease development and track disease progression.

Cite

CITATION STYLE

APA

Cisek, K., Krochmal, M., Klein, J., & Mischak, H. (2016, October 20). The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease. Nephrology Dialysis Transplantation. Oxford University Press. https://doi.org/10.1093/ndt/gfv364

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free